Related Experiment Video
Updated: Jul 14, 2026
08:47
Automated Analysis of C. elegans Swim Behavior Using CeleST Software
Published on: December 7, 2016
The complexity of aging: are some aging processes more equal than others?
1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Mechanisms of Ageing and Development
|July 3, 2007
Summary
Aging processes may not evolve to equal importance due to varying genetic susceptibility. However, lifespan extension in protected environments could make all age-related decline significant, challenging the role of protagonistic pleiotropies in aging.
Area of Science:
- Evolutionary biology
- Gerontology
- Genetics
Background:
- Aubrey de Grey's theory posits that independent age-related deteriorative processes evolve to equal importance.
- He suggests 'protagonistic pleiotropies' can disrupt this equality, where a single process affects multiple death causes.
- De Grey argues nDNA mutations, by causing cancer, become irrelevant to non-cancer aging.
Discussion:
- This paper questions the assumption of equal importance for independent aging processes.
- It highlights that inherent genetic susceptibility and evolutionary pressures influence the significance of each process.
- The concept of 'protagonistic pleiotropies' is re-evaluated in light of evolutionary dynamics.
Key Insights:
- Evolutionary arguments suggest aging processes may not naturally reach equal importance due to differential genetic susceptibility.
- In controlled environments with extended lifespans, all age-progressive degenerative processes could become significant contributors to aging.
- Protagonistic pleiotropies might be less effective in rendering processes irrelevant if multiple compensatory pathways exist.
Outlook:
- Further research into the evolutionary genetics of aging is warranted.
- Understanding the interplay between genetic factors and environmental influences on aging is crucial.
- This perspective may refine theories on lifespan extension and age-related disease prevention.
Related Concept Videos
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...